Animal (2023) ((EXCLUSIVE))
The Farm to Fork Strategy adopted by the Commission on 20 May 2020 announced that the Commission will, by the end of 2023, revise the animal welfare legislation to align it with the latest scientific evidence. In addition, the revision will broaden its scope, make its enforcement easier and ultimately ensure a higher level of animal welfare.
Animal (2023)
The Commission plans to revise the following pieces of legislation: the Directive on the protection of animals kept for farming purposes, four Directives laying down minimum standards for the protection of laying hens, broilers,pigs and calves; and the Regulations on the protection of animals during transport and at the time of killing.
In view of this revision, the Commission is preparing an Impact Assessment, whose objective is to assess the economic, social and environmental impact of the envisaged changes to the EU animal welfare legislation.
In September 2022, the Fitness Check was concluded. Its results, presented in a Commission Staff Working Document, confirms the need to revise and modernise the EU animal welfare legislation, and provides a good basis for this revision.
Also in view of this revision of the animal welfare legislation, the Commission has mandated the European Food Safety Authority (EFSA) to develop scientific opinions on the welfare of broilers; of calves; of pigs; of laying hens; of dairy cows; of ducks, geese and quails (when it comes to their housing conditions); as well as the welfare during transport of pigs, bovines, equids, small ruminants and animals transported in containers. In addition, the Commission sent a roadmap to EFSA summarising the animal welfare mandates it plans to send to EFSA between 2023 and 2028 to cover other animal species.
You can view alternative ways to comment or you may also comment via Regulations.gov at /documents/2023/03/07/2023-04668/wild-and-exotic-animal-handling-training-of-personnel-involved-with-public-handling-of-wild-and.
Beginning March 1, 2023, all foreign-vaccinated dogs entering the United States from rabies high-risk countries must have a valid CDC Rabies Vaccination and Microchip Record in addition to either a CDC Dog Import Permit or a reservation at a CDC-approved animal care facility. CDC will NOT accept foreign-issued pet passports or any other certificates for foreign rabies vaccinations.
The U.S. Food and Drug Administration has announced in the Federal Register the fiscal year (FY) 2023 fee rates and payment procedures for animal drugs subject to user fees under the Animal Drug User Fee Amendments of 2018 (ADUFA IV) and Animal Generic Drug User Fee Amendments of 2018 (AGDUFA III).
ADUFA, originally signed into law in 2003 and reauthorized in 2008, 2013 and 2018, amends the Federal Food, Drug, and Cosmetic Act (FD&C Act), and authorizes the FDA to collect fees for certain animal drug applications and supplemental applications, products, establishments, and sponsors of animal drug applications and/or investigational animal drug submissions. These resources supplement funding provided by Congressional budget authority to enhance the performance of the drug review process ensuring that new animal drug products are safe and effective for animals, and that food derived from treated animals will be safe for consumption. ADUFA IV reauthorizes the FDA to collect user fees through FY 2023.
AGDUFA, originally signed into law in 2008 and reauthorized in 2013 and 2018, was designed to supplement the Congressional budget authority to enhance the performance of the generic new animal drug review process, which enables the FDA to ensure that generic new animal drug products are safe and effective. AGDUFA III reauthorizes the FDA to collect user fees for certain abbreviated applications for generic new animal drugs, generic new animal drug products, and from certain sponsors of abbreviated applications for generic new animal drugs and/or investigational submissions for generic new animal drugs. The user fees for sponsors are prorated based on the number of approved abbreviated applications the sponsor currently holds. AGDUFA III reauthorizes the FDA to collect user fees through FY 2023.
In the period since Congress first passed ADUFA in 2003, the FDA has approved more than 499 new animal drugs -- both original approvals and major enhancements to these approvals (e.g., new indications, new species). In the period since AGDUFA was passed in 2008, the FDA has approved more than 323 generic new animal drugs.
We will be taking over the second floor for our 2023 conference to ensure all sessions, meals, sponsors, vendors, and our silent auction will be located in the same area. Our 2022 conference welcomed approximately 275 people from over 60 different animal welfare and protection agencies. We continue to build upon the success from prior years and we once again will be offering two and a half days of training, with four classroom tracks running simultaneously for most of the event. Our exhibit area will no doubt be action packed with approximately 25 different vendor displays, showcasing various products, programs, and services.
The Lunar New Year, or Spring Festival, marks the transition of the Chinese zodiac sign from one animal to the next. 2023 sees in the Year of the Rabbit, which begins on January 22. In Chinese culture, the Rabbit is a symbol of longevity, peace and prosperity. 2023 is predicted to be a year of hope.
The International Association for Aquatic Animal Medicine (IAAAM) is an organization of individuals who are professionally interested in and devote a significant amount of time to the practice of aquatic animal medicine, teaching and research in aquatic animal medicine, or the husbandry and management of aquatic animals.
This conference is open to all with interest in the planning, design, construction, and operation of animal research facilities. This includes research veterinarians, facility planners, capital project teams, project managers, engineering managers, architects, space planners, research compliance directors, animal and BSL facility operations managers, vivarium and BSL managers, animal resource managers, and biosafety officers. Product vendors must be sponsors or exhibitors to attend. The conference sessions are primarily aimed at equipping facility owners/end-users to make optimal project team, facility design, programming, and construction decisions.
The JRC is pleased to announce the fourth edition of its Summer School on Non-animal Approaches in Science: Towards Sustainable Innovation organised by the European Commission's Joint Research Centre and its EU Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM).
Non-animal approaches not only address the ethical aspects of using animals in science, but also offer huge advantages for conducting human relevant research and testing, whether it be for studying disease mechanisms, developing new therapies or ensuring the safe and sustainable use of chemicals.
We are looking for enthusiastic students or early-career scientists (max. 4 years after masters or PhD) with a strong interest in non-animal approaches working in relevant fields of research and application.
The ordinance does not apply to animal programs operated by Loudoun County Public Schools; wildlife rehabilitators, wildlife exhibitors or veterinary clinics which are properly licensed or permitted by the federal government or Commonwealth of Virginia; scientific research facilities; conservation police or animal control officers managing or transporting said animals in the line of duty; the department temporarily housing said animals, or a wildlife sanctuary as defined under the federal Lacey Act. Virginia law already restricts private ownership of many other wild and exotic animals, such as big cats and bears.
Congress passed a massive annual spending bill just before the New Year, which contains numerous provisions supporting the adoption of human-specific, nonanimal methods and reduced use of animals in federally funded experiments.
The Physicians Committee is pleased to see this progress, which was achieved, in part, due to our years of advocacy on both the need for more effective and ethical research and testing methods, and increased transparency and oversight of animal experiments. Although there is much more to do to permanently keep animals out of laboratories, it is encouraging to see these favorable provisions included in such wide-reaching legislation. The Physicians Committee looks forward to continuing to advocate for a future without animal experiments.
Twenty-eight teams gathered to devise and present their innovations to a panel of judges, competing for the $9,000 in prizes. They could solve any animal health challenge, but were also presented several challenges to choose from:
The current situation highlights the risk that H5N1 avian influenza may become better adapted to mammals, and spill over to humans and other animals. In addition, some mammals, such as mink, may act as mixing vessels for different influenza viruses, leading to the emergence of new strains and subtypes that could be more harmful to animals and/or humans. Recently reported infections in farmed mink are a concern because infections of large numbers of mammals kept in close proximity of each other exacerbate this risk. Several studies are currently on-going to further explore the virulence and transmissibility (including between mammals) of these viruses.
Taking Action for Animals (TAFA) brings together Humane Society of the United States volunteers, advocates and animal welfare organizations from across the country for one shared goal: to better the lives of animals and people alike. 041b061a72